Show simple item record

dc.contributor.authorPay, Gunes
dc.contributor.authorYaman, Mehmet
dc.contributor.authorUluduz, Derya
dc.contributor.authorKiziltan, Meral Erdemir
dc.contributor.authorYuksel, Seref
dc.date.accessioned2021-03-05T16:42:50Z
dc.date.available2021-03-05T16:42:50Z
dc.date.issued2007
dc.identifier.citationYaman M., Uluduz D., Yuksel S., Pay G., Kiziltan M. E. , "The cutaneous silent period in diabetes mellitus", NEUROSCIENCE LETTERS, cilt.419, ss.258-262, 2007
dc.identifier.issn0304-3940
dc.identifier.othervv_1032021
dc.identifier.otherav_c1f7354d-dca5-4f96-9b18-9540cb84ed6e
dc.identifier.urihttp://hdl.handle.net/20.500.12627/128721
dc.identifier.urihttps://doi.org/10.1016/j.neulet.2007.04.018
dc.description.abstractThe cutaneous silent period (CSP) may be useful as a method for the evaluation of smaller and unmyelinated fiber dysfunctions. CSP refers to the brief interruption in voluntary contraction that follows strong electrical stimulation of a cutaneous nerve. The aim the present study is to establish whether CSP can be instrumental in the determination of diabetic neuropathy. The nerve conduction studies and CSP evaluations were both used in patients with Diabetes Mellitus and control group. All patients were given clinical neurological examinations for the determination of small-fiber neuropathy (SFN). The CSP values for patients with SFN were compared with values of those without SFN. The nerve conduction velocities had changed unfavorably in diabetic patients. No median nerve CSP reponse could be obtained in two of the diabetic patients. CSP latency (84.6 +/- 14.0) in diabetics was longer than controls (76.2 +/- 13. 1) (p = 0.0 18). The duration of CSP was similar for the two groups (P = 0.46). The CSP latency showed a correlation with routine nerve conduction studies. While the CSP latencies (86.7 +/- 15.8) of patients who were clinically diagnosed with SFN were similar to the latencies (81.3 +/- 10.4) of patients without SFN (p = 0.606), the duration of CSP (44.6 +/- 13.7) in patients with SFN was shorter than the duration (55.3 +/- 12.2) in patients without SFN (p = 0.0 12). These results indicate that eventhough the CSP does not provide any advantage over routine electrodiagnostic studies in determining diabetic neuropathy, still it may be a useful method for the early detection of diabetic SFN. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
dc.language.isoeng
dc.subjectSinirbilim ve Davranış
dc.subjectNEUROSCIENCES
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.titleThe cutaneous silent period in diabetes mellitus
dc.typeMakale
dc.relation.journalNEUROSCIENCE LETTERS
dc.contributor.department, ,
dc.identifier.volume419
dc.identifier.issue3
dc.identifier.startpage258
dc.identifier.endpage262
dc.contributor.firstauthorID183078


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record